These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 25515529)

  • 1. Psoriasis-associated IgA nephropathy under infliximab therapy.
    Kluger N; Du-Thanh A; Bessis D; Servel MF; Mourad G
    Int J Dermatol; 2015 Mar; 54(3):e79-80. PubMed ID: 25515529
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of psoriasis with IgA nephropathy successfully treated with secukinumab.
    Kulaklı S; Akagün T
    Int J Dermatol; 2024 Feb; 63(2):e35-e37. PubMed ID: 37950460
    [No Abstract]   [Full Text] [Related]  

  • 3. Infliximab treatment in two patients with psoriatic arthritis and secondary IgA nephropathy.
    Sakellariou GT; Vounotrypidis P; Berberidis C
    Clin Rheumatol; 2007 Jul; 26(7):1132-3. PubMed ID: 16924391
    [No Abstract]   [Full Text] [Related]  

  • 4. IgA nephropathy in psoriasis.
    Ahuja TS; Funtanilla M; de Groot JJ; Velasco A; Badalamenti J; Wilson S
    Am J Nephrol; 1998; 18(5):425-9. PubMed ID: 9730568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgA nephropathy in a patient receiving infliximab for generalized pustular psoriasis.
    Segawa Y; Ishida R; Kanehisa F; Nakai K; Morimoto M; Seno M; Nakayama M; Kusaba T; Katoh N; Tamagaki K
    BMC Nephrol; 2020 Aug; 21(1):366. PubMed ID: 32842976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IgA nephropathy in a girl with psoriasis and seronegative arthritis.
    Wasilewska A; Zoch-Zwierz WM; Tenderenda E; Szynaka B
    Pediatr Dermatol; 2008; 25(3):408-9. PubMed ID: 18577065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pemphigus foliaceus coexisting with IgA nephropathy in a patient with psoriasis vulgaris.
    Perez GL; Agger WA; Abellera RM; Dahlberg P
    Int J Dermatol; 1995 Nov; 34(11):794-6. PubMed ID: 8543414
    [No Abstract]   [Full Text] [Related]  

  • 8. IgA nephropathy associated with hyper IgAnemia, psoriasis or pustulosis and ossification.
    Imai H; Kodama T; Ishino T; Yasuda T; Miura AB; Asakura K; Nishimura S; Nakamoto Y
    Clin Nephrol; 1995 Jul; 44(1):64-8. PubMed ID: 7554536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of severe erythrodermic psoriasis associated with IgA nephropathy.
    Nakamura-Wakatsuki T; Kato Y; Sakurai K; Yamamoto T
    Int J Dermatol; 2013 Dec; 52(12):1579-81. PubMed ID: 24261732
    [No Abstract]   [Full Text] [Related]  

  • 10. IgA nephropathy associated with pustulosis palmaris et plantaris.
    Saito T; Seino J; Sato H; Maebashi M; Kita A; Tagami H; Abe K
    Clin Nephrol; 1994 Dec; 42(6):405-6. PubMed ID: 7882607
    [No Abstract]   [Full Text] [Related]  

  • 11. Improvement of anti-TNFα antibody-induced pustular psoriasis by azathioprine.
    Kayama T; Otsuka A; Miyachi Y; Kabashima K
    Eur J Dermatol; 2012; 22(4):565-6. PubMed ID: 22853939
    [No Abstract]   [Full Text] [Related]  

  • 12. IgA nephropathy associated with ankylosing spondylitis is not controlled by infliximab therapy.
    Jacquet A; Francois H; Frangie C; Yahiaoui Y; Ferlicot S; Micelli C; Mariette X; Durrbach A
    Nephrol Dial Transplant; 2009 Nov; 24(11):3540-2. PubMed ID: 19556300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteomyelitis occurring during infliximab treatment of severe psoriasis.
    Sri JC; Tsai CL; Deng A; Gaspari AA
    J Drugs Dermatol; 2007 Feb; 6(2):207-10. PubMed ID: 17373180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infliximab for patients with plaque psoriasis and severe psychiatric comorbidity.
    Bassukas ID; Hyphantis T; Gamvroulia C; Gaitanis G; Mavreas V
    J Eur Acad Dermatol Venereol; 2008 Feb; 22(2):257-8. PubMed ID: 18211435
    [No Abstract]   [Full Text] [Related]  

  • 15. [A case of IgA nephropathy associated with psoriasis vulgaris].
    Yamamoto M; Yorioka T; Kawada M; Nishimura K; Kumon Y; Yasuoka N; Suehiro T; Hashimoto K
    Nihon Jinzo Gakkai Shi; 1994 Jun; 36(6):779-83. PubMed ID: 8084081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of tumor necrosis factor inhibitors in acute generalized pustular psoriasis.
    Viguier M; Aubin F; Delaporte E; Pagès C; Paul C; Beylot-Barry M; Goujon C; Rybojad M; Bachelez H;
    Arch Dermatol; 2012 Dec; 148(12):1423-5. PubMed ID: 23247492
    [No Abstract]   [Full Text] [Related]  

  • 17. Flare and change of psoriasis morphology during the course of treatment with tumour necrosis factor blockers.
    Goiriz R; Daudén E; Pérez-Gala S; Guhl G; García-Díez A
    Clin Exp Dermatol; 2007 Mar; 32(2):176-9. PubMed ID: 17176269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An unusual case of IgA-dominant membranoproliferative glomerulonephritis associated with psoriasis vulgaris.
    Tan HZ; Loh AHL; Choo CJJ; Lim CC
    Int Urol Nephrol; 2021 Sep; 53(9):1951-1952. PubMed ID: 33387230
    [No Abstract]   [Full Text] [Related]  

  • 19. Remission and time of resolution of nail psoriasis during infliximab therapy.
    Bianchi L; Bergamin A; de Felice C; Capriotti E; Chimenti S
    J Am Acad Dermatol; 2005 Apr; 52(4):736-7. PubMed ID: 15793554
    [No Abstract]   [Full Text] [Related]  

  • 20. Life-threatening pustular and erythrodermic psoriasis responding to infliximab.
    Lewis TG; Tuchinda C; Lim HW; Wong HK
    J Drugs Dermatol; 2006 Jun; 5(6):546-8. PubMed ID: 16774108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.